119744-44-4

Basic information

• Product Name: N-(tert-Butyloxycarbonyl)-3-(4-nitrophenyl)propylamine
• Synonyms: N-(tert-Butyloxycarbonyl)-3-(4-nitrophenyl)propylamine
• CAS NO: 119744-44-4
• Molecular Weight: 280.324
• Mol File: 119744-44-4.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: N-(tert-Butyloxycarbonyl)-3-(4-nitrophenyl)propylamine(CAS DataBase Reference)
• NIST Chemistry Reference: N-(tert-Butyloxycarbonyl)-3-(4-nitrophenyl)propylamine(119744-44-4)
• EPA Substance Registry System: N-(tert-Butyloxycarbonyl)-3-(4-nitrophenyl)propylamine(119744-44-4)

Safety Data

• Hazardous Substances Data: 119744-44-4(Hazardous Substances Data)

Upstream product

• 75-65-0 tert-butyl alcohol 
• 2038-57-5 3-Phenylpropan-1-amine 
• 24424-99-5 di-tert-butyl dicarbonate 
• 637-59-2 1-Bromo-3-phenylpropane 
• 53712-77-9 1-bromo-3-(4-nitrophenyl)propane 
• 93324-23-3 N-[3-(4-nitrophenyl)propyl]-phthalimide 
• 636-98-6 p-nitrobenzene iodide 
• 78888-18-3 N-tert-butoxycarbonylprop-2-en-1-amine 
• 80258-61-3 3-(4-nitrophenyl)propan-1-amine 
• 6555-33-5 3(R)-(4-nitrophenyl)butanoic acid 

Downstream Products

• 56946-60-2 3-(4-nitro-phenyl)-propylamine; hydrochloride 

Relevant articles and documents

A novel series of 2-carboxytetrahydroquinolines provides new insights into the eastern region of glycine site NMDA antagonists

A series of potent 4-substituted tetrahydroquinolines has been synthesized and biologically tested in order to refine the eastern region of the pharmacophore model for glycine site NMDA antagonists concerning the assessment of lipophilicity, flexibility, and hydrogen bonding. Displacement studies on rat cortical membranes using [3H]-5,7-dichlorokynurenic acid as a radioligand indicated that binding affinities are markedly enhanced when additional hydrogen-accepting groups are introduced into the eastern region of the 2-carboxytetrahydroquinolines. Among the most potent ligands were some urea, sulfonylurea, and crown ether compounds as interesting leads for new diagnostics, especially for the evaluation of PET tracers, which allow biodistribution studies and NMDA receptor studies in the living organism.

CHLORO-PYRAZINE CARBOXAMIDE DERIVATIVES WITH EPITHELIAL SODIUM CHANNEL BLOCKING ACTIVITY

This invention provides compounds of the formula I: and their pharmaceutically acceptable salts, useful as sodium channel blockers, compositions containing the same, therapeutic methods and uses for the same and processes for preparing the same.

Synthesis and evaluation of novel phenylethanolamine derivatives containing acetanilides as potent and selective b 3-adrenergic receptor agonists

In the search for potent and selective human β3-adrenergic receptor (AR) agonists as potential pharmacotherapies for the treatment of obesity and non-insulin dependent (type II) diabetes, we prepared a novel series of phenylethanolamine derivatives containing acetanilides and evaluated their biological activities at the human β3-, β2-, and β1-ARs. Among these compounds, the 6-amino-2-pyridylacetanilide (36b), 2-amino-5- methylthiazol- 4-ylacetanilide (36g), and 5-amino-1,2,4-thiadiazol-3- ylacetanilide (36h) derivatives showed potent agonistic activity at the β3-AR with functional selectivity over the β1- and β2-ARs. In addition, these compounds exhibited significant hypoglycemic activity in a rodent diabetic model.